- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02559479
A Study to Assess the Effect of a Normal vs. High Protein Diets in Carbohydrates Metabolism in Obese Subjects With Diabetes or Prediabetes
December 1, 2016 updated by: Fernando Civeira, Instituto Aragones de Ciencias de la Salud
The objective of the study is to assess the effect of low-calorie diets with normal (18%) vs. high (35%) protein (mainly coming from animal source) composition on body weight and carbohydrates metabolism in overweight and obese subjects with pre-diabetes or diabetes.
A dietary intervention is carried out during 6 months in 100 subjects who are individually randomized to an energy-restricted diet with two types of macronutrients composition: 1) 35% protein, 30% fat and 35% carbohydrates and 2) 18% protein, 30% fat and 52% carbohydrates.
Around 80% of total protein in diet comes from animal source (of whom around 40% from lean red meat).
Subjects are provided with weekly menus and different recipes to use them as part of the diet.
Monitoring visits with the nutritionist will be performed every 15 days.
At the beginning of the study, after 3 and 6 months, the following parameters are determined: anthropometric (weight, waist circumference, body mass index and body composition), blood pressure, dietary (72-hours dietary registry) and exercise and biochemical analysis (total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol, apolipoproteins A1 and B, iron, transferring, ferritin, uric acid, glucose, HbA1c, insulin, adiponectin and resistin).
Urine samples are also collected to assess microalbuminuria and ureic nitrogen.
Study Overview
Status
Unknown
Conditions
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Fernando Civeira, MD, PhD
- Phone Number: 2884 +34 976765500
- Email: civeira@unizar.es
Study Contact Backup
- Name: Rocio Mateo-Gallego, RD, PhD
- Email: rmateo.iacs@aragon.es
Study Locations
-
-
-
Zaragoza, Spain, 50009
- Recruiting
- Fernando Civeira
-
Contact:
- Rocio Mateo-Gallego, RD, PhD
- Phone Number: 2895 +34 976765500
- Email: rmateo.iacs@aragon.es
-
Contact:
- Victoria Marco-Benedí, RD
- Phone Number: 2895 +34 976765500
- Email: vito2911@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age: 18-70 years old.
- Body mass index between 27.5 - 40.
- Steady weight (± 4 kg) in the last 2 months.
- Glycated hemoglobin between 6 - 7%.
Exclusion Criteria:
- Anti-diabetic drugs (oral or subcutaneous) in the last 2 months.
- Lipid-lowering drugs in the last 2 months.
- Gouty arthritis in the last 2 years or uric acid > 735 mg/dl.
- Presence of uncontrolled endocrinological pathology (including hypothyroidism).
- Hepatic chronic disease (glomerular filtration rate < 45 ml/min).
- Renal, inflammatory or tumoral diseases.
- Drugs which could interfere in glucose or lipid metabolism such as androgens, corticosteroids (except for those with topic administration) and estrogen replacement therapy.
- Intake of functional foods with plant sterols in the past 6 weeks.
- High alcohol intake (> 30 g per day).
- Any serious disease which involves less than 1 year life expectancy or, in investigators judgment, limit the follow-up of an homogeneous diet throughout the study.
- Pregnancy or intention of pregnancy during the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 18%-Protein diet
Energy-restricted diet wit the following composition: 18% protein, 30% fat and 52% carbohydrates
|
|
Active Comparator: 35%-Protein diet
Energy-restricted diet wit the following composition: 35% protein, 30% fat and 35% carbohydrates
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in glucose.
Time Frame: After 3 and 6 months of intervention.
|
After 3 and 6 months of intervention.
|
Change in glycated hemoglobin.
Time Frame: After 3 and 6 months of intervention.
|
After 3 and 6 months of intervention.
|
Change in insulin resistance (HOMA index).
Time Frame: After 3 and 6 months of intervention.
|
After 3 and 6 months of intervention.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in body weight.
Time Frame: After 3 and 6 months of intervention.
|
After 3 and 6 months of intervention.
|
Change in body composition.
Time Frame: After 3 and 6 months of intervention.
|
After 3 and 6 months of intervention.
|
Change in waist circumference.
Time Frame: After 3 and 6 months of intervention.
|
After 3 and 6 months of intervention.
|
Change in lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, non HDL cholesterol, triglycerides and apolipoproteins).
Time Frame: After 3 and 6 months of intervention.
|
After 3 and 6 months of intervention.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Fernando Civeira, MD, PhD, Unidad Clínica y de Investigación en Lípidos y Arteriosclerosis; Hospital U. Miguel Servet; IIS Aragón
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2015
Primary Completion (Anticipated)
June 1, 2017
Study Completion (Anticipated)
June 1, 2017
Study Registration Dates
First Submitted
September 22, 2015
First Submitted That Met QC Criteria
September 23, 2015
First Posted (Estimate)
September 24, 2015
Study Record Updates
Last Update Posted (Estimate)
December 2, 2016
Last Update Submitted That Met QC Criteria
December 1, 2016
Last Verified
December 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEICA;PI/15/0183
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Weight loss interventional study with a low-calorie 18%-protein diet
-
Instituto Aragones de Ciencias de la SaludCompletedObesity | Overweight | Weight Loss | Diet, Reducing | Lipids
-
National University Hospital, SingaporeEnrolling by invitationObesity | Metabolic Syndrome | Weight Loss | Ketogenic DietingSingapore
-
King's College LondonLighterlife Ltd (UK)Completed
-
Rockefeller UniversityCompleted
-
University Hospital, RouenNot yet recruitingBariatric Surgery Candidate | Diet, Healthy | Obesity, Visceral
-
PfizerTerminatedObesityUnited States, Australia, Denmark, Netherlands, South Africa
-
University Medical Center, KazakhstanCompleted
-
Mahitab Mohammed Yosri IbrahimCompletedPolycystic Ovary Syndrome
-
Universidad de ZaragozaCompletedDiabetes Mellitus, Type 2 | PreDiabetes | Overweight and ObesitySpain
-
Washington University School of MedicineRecruitingObesity | Insulin Resistance | Obesity, Metabolically Benign | Metabolically Healthy ObesityUnited States